{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:55:38Z","timestamp":1790920538267,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[1996,4]]},"abstract":"<jats:p>\n            <jats:italic>Abstract<\/jats:italic>\n            Plasma concentrations of both atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are elevated in severe hypertension, acute myocardial infarction, and heart failure. In the current study of individuals with essential hypertension, we have documented the hemodynamic, hormonal, and endocrine effects of infusions of these two peptides given alone or in combination in equimolar doses calculated to induce increments in plasma peptides to concentrations (30 to 60 pmol\/L) observed in these disease states. The metabolic clearance rate of ANP (4.56\u00b10.62 L\/min) was greater than that for BNP (3.4\u00b10.23 L\/min,\n            <jats:italic>P<\/jats:italic>\n            &lt;.001). Infusions of each cardiac hormone impaired the clearance of coinfused peptide. All peptide infusions enhanced natriuresis (17% to 70% above preinfusion levels versus placebo, 6%;\n            <jats:italic>P<\/jats:italic>\n            &lt;.001), lowered blood pressure (10 to 18 mm Hg fall in mean arterial pressure below placebo levels;\n            <jats:italic>P<\/jats:italic>\n            &lt;.001), increased hematocrit, suppressed the renin-angiotensin-aldosterone system, and enhanced plasma norepinephrine concentrations. The natriuretic and blood pressure\u2013lowering effects of BNP were twofold to threefold those of ANP. In contrast, ANP-induced increments in plasma and urinary second messenger (cGMP) levels were greater than those for BNP. Both peptides suppressed the renin-angiotensin-aldosterone system (approximately one-third fall in renin activity and plasma aldosterone) and enhanced plasma norepinephrine concentrations (+30%) to a similar degree. Increments in plasma ANP and BNP that occur simultaneously in cardiovascular disease states appear capable of causing hemodynamic, endocrine, and renal effects that would tend to ameliorate conditions such as hypertension or heart failure.\n          <\/jats:p>","DOI":"10.1161\/01.hyp.27.4.906","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:53:46Z","timestamp":1339462426000},"page":"906-913","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":33,"title":["Differing Metabolism and Bioactivity of Atrial and Brain Natriuretic Peptides in Essential Hypertension"],"prefix":"10.1161","volume":"27","author":[{"given":"Grant B.","family":"Pidgeon","sequence":"first","affiliation":[{"name":"From the Department of Medicine, Christchurch (New Zealand) School of Medicine, Christchurch Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Mark","family":"Richards","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Christchurch (New Zealand) School of Medicine, Christchurch Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Gary","family":"Nicholls","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Christchurch (New Zealand) School of Medicine, Christchurch Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Espiner","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Christchurch (New Zealand) School of Medicine, Christchurch Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim G.","family":"Yandle","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Christchurch (New Zealand) School of Medicine, Christchurch Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Frampton","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Christchurch (New Zealand) School of Medicine, Christchurch Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90653-7"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.10.6.570"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/4.10.850"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.7.5.812"},{"key":"e_1_3_2_5_2","unstructured":"Weidmann P Gnadinger MP Ziswiler HR Shaw S Bachmann C Rascher W Uehlinger DE Hasler L Reubi FC. Cardiovascular endocrine and renal effects of atrial natriuretic peptide in essential hypertension. J Hypertens. 1986;4(suppl 2):S71-S83."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.80.4.2529059"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.14.3.261"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.13.6.640"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/332078a0"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-70-4-1103"},{"key":"e_1_3_2_11_2","first-page":"91","volume":"76","year":"1993","unstructured":"Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C. Renal, endocrine and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab. 1993;76:91-96.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0860723"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0880081"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.84.4.1914098"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199302000-00008"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.25.5.1053"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(86)90137-2"},{"key":"e_1_3_2_18_2","first-page":"R1244","volume":"266","year":"1994","unstructured":"Florkowski CM, Richards AM, Espiner EA, Yandle TG, Frampton C. Renal, endocrine, and haemodynamic interactions of atrial and brain natriuretic peptides in normal men. Am J Physiol. 1994;266:R1244-R1250.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_19_2","unstructured":"Hunt PJ Espiner EA Richards AM Yandle TG Frampton C Nicholls MG. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men. Am J Physiol. In press."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90011-Y"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(05)81311-7"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2935937"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)93126-L"},{"key":"e_1_3_2_24_2","unstructured":"Varley H ed. Practical Clinical Chemistry. 4th ed. London UK: Heinemann; 1967:175-179."},{"key":"e_1_3_2_25_2","first-page":"71","volume":"61","year":"1986","unstructured":"Yandle T, Espiner E, Nicholls M, Duff H. Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma. J Clin Endocrinol Metab. 1986;61:71-78.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_2_26_2","first-page":"832","volume":"76","year":"1993","unstructured":"Yandle T, Richards A, Gilbert A, Fisher S, Holmes S, Espiner E. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab. 1993;76:832-838.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)45621-4"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1976.tb03306.x"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/29.2.268"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(81)90139-9"},{"key":"e_1_3_2_31_2","unstructured":"Wilkinson L. SYSTAT. The System for Statistics. Evanston Ill: Systat Inc; 1990."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-66-3-465"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115146"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2910083"},{"key":"e_1_3_2_35_2","first-page":"F520","volume":"250","year":"1986","unstructured":"Sosa RE, Volpe M, Marion DN, Atlas SA, Laragh JH, Vaughan ED, Maack T. Relationship between renal, hemodynamic and natriuretic effects of atrial natriuretic factor. Am J Physiol. 1986;250:F520-F524.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_36_2","first-page":"F146","volume":"252","year":"1987","unstructured":"Davis CL, Briggs JP. Effect of reduction in renal artery pressure on atrial natriuretic peptide-induced natriuresis. Am J Physiol. 1987;252:F146-F153.","journal-title":"Am J Physiol"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.27.4.906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T17:44:01Z","timestamp":1715535841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.27.4.906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1996,4]]}},"alternative-id":["10.1161\/01.HYP.27.4.906"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.27.4.906","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,4]]},"assertion":[{"value":"1995-10-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1995-12-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1996-04-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}